Stéphanie Dulucq

Multidrug resistance gene (MDR1) polymorphisms are associated with major molecular responses to standard-dose imatinib in chronic myeloid leukemia

Stéphanie Dulucq, Stéphane Bouchet, Béatrice Turcq et al. · Blood · 2008 · 233 citations

Medicine, Genetics, Molecular Genetics +15

Evaluation of Residual Disease and TKI Duration Are Critical Predictive Factors for Molecular Recurrence after Stopping Imatinib First-line in Chronic Phase CML Patients

Franck E. Nicolini, Stéphanie Dulucq, Lisa Boureau et al. · Clinical Cancer Research · 2019 · 110 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Characterization and Clinical Significance of Hemolysis After Pulsed Field Ablation for Atrial Fibrillation: Results of a Multicenter Analysis

Miruna Popa, Sandrine Venier, Roberto Menè et al. · Circulation Arrhythmia and Electrophysiology · 2024 · 100 citations

Medicine, Cardiology, Hematology +15

Quantitative phosphoproteomics revealed interplay between Syk and Lyn in the resistance to nilotinib in chronic myeloid leukemia cells

Romain Gioia, Cédric Leroy, Claire Drullion et al. · Blood · 2011 · 99 citations · Full text

Medicine, Cell Biology, Molecular Biology +14

DNA variants in the dihydrofolate reductase gene and outcome in childhood ALL

Stéphanie Dulucq, Geneviève St‐Onge, Vincent Gagné et al. · Blood · 2007 · 97 citations

Life Sciences, Genetics, Molecular Genetics +14